ATE307610T1 - Verfahren zum stabilisieren von arylcarbonsäuren, dafür verwendbarer stabilisator und eine stabilisierte carbonsäure enthaltende wässrige lösung - Google Patents

Verfahren zum stabilisieren von arylcarbonsäuren, dafür verwendbarer stabilisator und eine stabilisierte carbonsäure enthaltende wässrige lösung

Info

Publication number
ATE307610T1
ATE307610T1 AT03025332T AT03025332T ATE307610T1 AT E307610 T1 ATE307610 T1 AT E307610T1 AT 03025332 T AT03025332 T AT 03025332T AT 03025332 T AT03025332 T AT 03025332T AT E307610 T1 ATE307610 T1 AT E307610T1
Authority
AT
Austria
Prior art keywords
aqueous solution
stabilizing
solution containing
carboxylic acid
arylcarboxylic acids
Prior art date
Application number
AT03025332T
Other languages
English (en)
Inventor
Sawa Shirou
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE307610T1 publication Critical patent/ATE307610T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT03025332T 1997-02-04 1998-02-03 Verfahren zum stabilisieren von arylcarbonsäuren, dafür verwendbarer stabilisator und eine stabilisierte carbonsäure enthaltende wässrige lösung ATE307610T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2180597 1997-02-04

Publications (1)

Publication Number Publication Date
ATE307610T1 true ATE307610T1 (de) 2005-11-15

Family

ID=12065276

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98101804T ATE253891T1 (de) 1997-02-04 1998-02-03 Verfahren zum stabilisieren von arylcarbonsäuren, dafür verwendbaren stabilisator und eine stabilisierte carbonsäure enthaltende wässrige lösung
AT03025332T ATE307610T1 (de) 1997-02-04 1998-02-03 Verfahren zum stabilisieren von arylcarbonsäuren, dafür verwendbarer stabilisator und eine stabilisierte carbonsäure enthaltende wässrige lösung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98101804T ATE253891T1 (de) 1997-02-04 1998-02-03 Verfahren zum stabilisieren von arylcarbonsäuren, dafür verwendbaren stabilisator und eine stabilisierte carbonsäure enthaltende wässrige lösung

Country Status (7)

Country Link
US (3) US6274592B1 (de)
EP (2) EP0856310B1 (de)
KR (1) KR100506484B1 (de)
AT (2) ATE253891T1 (de)
CA (1) CA2228536A1 (de)
DE (2) DE69819569D1 (de)
ES (1) ES2250814T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK286420B6 (sk) 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
WO2003005969A2 (en) 2001-07-12 2003-01-23 Bristol-Myers Squibb Pharma Company Tetrahydropurinones as corticotropin releasing factor
CN1578781A (zh) 2001-09-26 2005-02-09 拜尔药品公司 用作抗糖尿病药物的1,8－萘啶衍生物
PT1586316E (pt) 2003-01-21 2008-05-28 Senju Pharma Co Preparação líquida aquosa contendo ácido 2-amino-3-(4- bromobenzoil)fenilacético
MX2008012488A (es) 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
CA2647457C (en) 2006-03-28 2011-05-24 The Procter & Gamble Company A hydride reduction process for preparing quinolone intermediates
EP2001862B1 (de) 2006-03-28 2011-04-27 Warner Chilcott Company, LLC Malatsalze und polymorphe von (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure
CA2824433C (en) 2011-01-18 2019-11-12 Senju Pharmaceutical Co., Ltd. Aqueous liquid bromfenac composition having preservative efficacy
WO2013031935A1 (ja) * 2011-08-31 2013-03-07 興和株式会社 安定な医薬組成物
PT4426434T (pt) 2021-11-02 2025-11-24 Flare Therapeutics Inc Agonistas inversos de pparg e suas utilizações
WO2023205463A1 (en) 2022-04-22 2023-10-26 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB873526A (en) 1957-08-14 1961-07-26 Upjohn Co Fluid compositions comprising (acetyl-salicylic acid)-anhydride
US4339428A (en) 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4559343A (en) 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
EP0173729B1 (de) 1984-03-14 1990-10-17 Jérôme CORBIERE Verfahren zum lösen von wirksubstanzen und auf diese weise erhaltene arzneimittel
IL80459A (en) 1986-10-30 1991-04-15 Abic Ltd Water-soluble adduct of norfloxacin and nicotinic acid
IT1226940B (it) 1988-09-16 1991-02-22 Recordati Chem Pharm Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
CA1336687C (en) 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
US5296228A (en) 1992-03-13 1994-03-22 Allergan, Inc. Compositions for controlled delivery of pharmaceutical compounds
ES2065846B1 (es) * 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
ATE177635T1 (de) 1993-04-22 1999-04-15 Senju Pharma Co Wässrige arzneizubereitungen enthaltend argatroban und cyclodextrin oder coffein
JPH0797325A (ja) 1993-06-30 1995-04-11 Takeda Chem Ind Ltd 安定な固形製剤およびその製造法
AU676315B2 (en) 1993-06-30 1997-03-06 Takeda Chemical Industries Ltd. Stabilized solid pharmaceutical preparation and method of producing the same
HUT72408A (en) 1993-09-10 1996-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing tablets containing acetyl-salicylic acid
US5641512A (en) 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
JP3170619B2 (ja) * 1995-04-20 2001-05-28 参天製薬株式会社 有機アミンを配合したプラノプロフェン点眼液
JPH08333246A (ja) 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
JPH08333265A (ja) 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
JP3382076B2 (ja) 1995-12-12 2003-03-04 佐藤製薬株式会社 イブプロフェンを溶解してなるかぜ薬軟カプセル及びその製造方法
GB9613457D0 (en) 1996-06-27 1996-08-28 Procter & Gamble Pharmaceutical compositions
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid

Also Published As

Publication number Publication date
US7320985B2 (en) 2008-01-22
ES2250814T3 (es) 2006-04-16
EP0856310A2 (de) 1998-08-05
EP1389469B1 (de) 2005-10-26
CA2228536A1 (en) 1998-08-04
US6274592B1 (en) 2001-08-14
ATE253891T1 (de) 2003-11-15
DE69832115D1 (de) 2005-12-01
DE69819569D1 (de) 2003-12-18
EP1389469A1 (de) 2004-02-18
US20010056098A1 (en) 2001-12-27
EP0856310A3 (de) 2000-01-19
DE69832115T2 (de) 2006-07-13
KR19980071023A (ko) 1998-10-26
EP0856310B1 (de) 2003-11-12
US20050075350A1 (en) 2005-04-07
KR100506484B1 (ko) 2005-11-16

Similar Documents

Publication Publication Date Title
ATE307610T1 (de) Verfahren zum stabilisieren von arylcarbonsäuren, dafür verwendbarer stabilisator und eine stabilisierte carbonsäure enthaltende wässrige lösung
ATE13422T1 (de) Derivate von 1-aryl-2-aminomethyl-cyclopropancarboxamiden (z), ihre herstellung und ihre verwendung fuer die behandlung von stoerungen des zentralnervensystems.
ATE170513T1 (de) Diastereomeres salz von optisch aktiver chinolinmevalonsäure
NO873568D0 (no) Alfa-alkyl-4-amino-kinolinmetanoler og 1-(4-aralkylamino-3kinolinyl)alkanoler, samt fremgangsmaate for fremstilling derav.
ES2132284T3 (es) Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
DK0882725T3 (da) Quinoloncarboxylsyrederivater eller deres salte
DK506587A (da) Imidderivater
NO20005660D0 (no) Nye mellomprodukter og fremgangsmåter for fremstilling av optisk aktive oktansyrederivater
ES514463A0 (es) "procedimiento de escision enzimatica de derivados de insulina".
DK0415102T3 (da) 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-oner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ATE239505T1 (de) Verfahren zum löslichmachen von pyridoncarbonsäuren mit hilfe von arylcarbonsäuren als lösungsvermittler
TW256831B (de)
EP0718281A4 (de) Cyclohexandiharnstoff-derivate und verfahren zu deren herstellung
ATE172734T1 (de) Verfahren zur herstellung von ceftriaxon
ATE389010T1 (de) Verfahren zur herstellung von optisch aktiven pyridinethanol-derivaten
DE60104986D1 (de) Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis
DK0850931T3 (da) Fremgangsmåde til fremstilling af optisk aktive (R eller S)-1-(4-methoxybenzyl)-1,2,3,4,5,6,7,8-octahydro-isoquinoliner
DE3789409D1 (de) Verfahren zur Herstellung von Chinolin-2,3-Carbonsäure.
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
BR9405262A (pt) Processo para a preparação de um ácido piridina-2,3-dicarboxílico
DE3262353D1 (en) N,n-disubstituted alkenamides and phenylalkenamides, processes for their production and their use as pharmaceuticals
PT83715B (pt) Processo para a preparacao de novos derivados de piperidina
GB1387595A (en) Substituted quinolines
ATE120741T1 (de) N-hydroxy-dibenz(b,e>oxepin-alkylamine und - alkanoische säureamide, verwandte heterocyclische analoge, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
DE69816773D1 (de) Verfahren zur herstellung von 1,4-benzodioxan-derivaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties